ClinicalTrials.Veeva

Menu
A

Atlanta Behavioral Research, LLC | Atlanta, GA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Esketamine
SEP-4199
NMRA-335140
Cariprazine
SEP-363856
Ecopipam Hydrochloride
BTRX-335140
54135419SUI3002
Centanafadine
JNJ-67953964

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 13 total trials

A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)

The primary purpose of this trial is to evaluate the safety and tolerability of centanafadine QD XR in pediatric subjects with ADHD.

Active, not recruiting
Attention Deficit/Hyperactivity Disorder
Drug: Centanafadine Hydrochloride

The purpose of this study is to evaluate the efficacy and safety of cariprazine in the treatment of schizophrenia in the adolescent population.

Enrolling
Schizophrenia
Drug: Cariprazine
Drug: Placebo

Trial sponsors

Janssen (J&J Innovative Medicine) logo
Otsuka logo
Sumitomo Pharma logo
Allergan logo
B
E
G

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems